NUCLEOSIDE LINE-1 INHIBITORS
Publication
EP4499106A2
Kind: A2
Mar 25, 2026
Applicants
Transposon Therapeutics, Inc.
Inventors
WEBER, Eckard, CORDINGLEY, Michael, G., BURNIE, Andrew, James, BROWN, William, DARAPANENI, Chandra Mohan, PALADINO, Marco, DOSHI, Malay, PATEL, Jigneshkumar Jashbhai
IPC Classifications
C07D 405/04 20060101AFI20260213BHEP
C07D 409/04 20060101ALI20260213BHEP
C07D 473/00 20060101ALI20260213BHEP
C07D 487/04 20060101ALI20260213BHEP
C07H 19/056 20060101ALI20260213BHEP
C07H 19/067 20060101ALI20260213BHEP
C07H 19/073 20060101ALI20260213BHEP
C07H 19/167 20060101ALI20260213BHEP
C07H 19/173 20060101ALI20260213BHEP
C07H 19/23 20060101ALI20260213BHEP
A61K 31/522 20060101ALI20260213BHEP
A61K 31/519 20060101ALI20260213BHEP
C07F 9/6561 20060101ALI20260213BHEP
A61K 31/513 20060101ALI20260213BHEP
A61P 25/28 20060101ALI20260213BHEP
A61P 35/00 20060101ALI20260213BHEP
A61P 37/00 20060101ALI20260213BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR